SCHEMBL29923950

SCHEMBL29923950

CNc1ncnc2nc(O)[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 5/20 0.41
▸ PDPK1 O15530 1/20 0.40
▸ YTHDC1 Q96MU7 2/20 0.39
▸ YTHDF2 Q9Y5A9 2/20 0.39
▸ CSF1R P07333 2/20 0.38
▸ XDH P47989 1/20 0.37
▸ EGFR P00533 1/20 0.36
▸ CYP1A2 P05177 3/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ NUDT1 P36639 2/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ TBK1 Q9UHD2 1/20 0.32
▸ CDK2 P24941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL355788 1.00 GSK3B (0.41) GSK3BPDPK1YTHDC1YTHDF2CSF1R
SCHEMBL20420132 0.81 AKT2 (0.42) GSK3BPDPK1YTHDC1YTHDF2CSF1R
SCHEMBL355787 0.76 YTHDC1 (0.43) PDPK1YTHDC1YTHDF2CSF1REGFR
SCHEMBL11918991 0.76 NUDT1 (0.36) GSK3BCSF1RNUDT1ADORA2AADORA1
SCHEMBL10217115 0.75 FFAR2 (0.36) NUDT1ADORA2AADORA1
SCHEMBL2639251 0.75 ADORA2A (0.37) GSK3BCSF1RNUDT1ADORA2AADORA1
SCHEMBL14778797 0.73 CSF1R (0.71) CSF1REGFRCYP1A2CYP2D6CDK2
SCHEMBL2371959 0.72 JAK2 (0.46) GSK3BCSF1REGFR
SCHEMBL8823867 0.72 ADORA2A (0.35) GSK3BNUDT1ADORA2AADORA1
SCHEMBL42335 0.72 ADORA2A (0.61) XDHNUDT1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4683716-A1 DNA NANODEVICES FOR SPECIFIC AND EFFICIENT DELIVERY OF FUNCTIONAL PAYLOADS TO THE CYTOPLASM AND METHODS OF THEIR USE Arizona Board of Regents on behalf of Arizona State University (US) 2026-01-28 — — EP disclosed
EP-4680212-A1 ADAR1 INHIBITORS FOR TREATING CANCER Institute of Cancer Research Royal Cancer Hospital (GB) 2026-01-21 — — EP disclosed
EP-4658317-A1 PROGRAMMABLE DNA PROTEOLYSIS TARGET CHIMERAS AND METHODS OF THEIR USE Arizona Board of Regents on behalf of Arizona State University (US) 2025-12-10 — — EP disclosed
WO-2025051818-A1 METHODS FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW (GB) 2025-03-13 — — WO disclosed
WO-2025015018-A1 CONDITIONAL PROTEOLYSIS GENE SILENCING TARGETING CHIMERA AND METHODS OF USE THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2025-01-16 — — WO disclosed
WO-2024196422-A1 DNA NANODEVICES FOR SPECIFIC AND EFFICIENT DELIVERY OF FUNCTIONAL PAYLOADS TO THE CYTOPLASM AND METHODS OF THEIR USE ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-09-26 — — WO disclosed
WO-2024189433-A1 ADAR1 INHIBITORS FOR TREATING CANCER INSTITUE OF CANCER RESEARCH ROYAL CANCER HOSPITAL (GB) 2024-09-19 — — WO disclosed
EP-4415827-A1 PROGRAMMABLE DELIVERY PLATFORMS FOR RNA STRUCTURES Arizona Board of Regents on behalf of Arizona State University (US) 2024-08-21 — — EP disclosed
WO-2024163374-A1 PROGRAMMABLE DNA PROTEOLYSIS TARGET CHIMERAS AND METHODS OF THEIR USE ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-08-08 — — WO disclosed
WO-2024081922-A1 MODULAR RNA DELIVERY PLATFORMS AND METHODS OF THEIR USE ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-04-18 — — WO disclosed
WO-2023064937-A1 PROGRAMMABLE DELIVERY PLATFORMS FOR RNA STRUCTURES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2023-04-20 — — WO disclosed
EP-4054592-A1 MICROBIAL DETECTION PLATFORM Nuclease Probe Technologies, Inc. (US) 2022-09-14 — — EP disclosed
Send feedback